Bloomberg Reveals Sinovac Vaccine Report Found to be highly effective From the actual injection trial In Indonesia And Brazil Critical illness and lower mortality rates But need to inject a large proportion of the population
Images from Vladimka production / Shutterstock.com.
In Indonesia Has mobilized the Sinovac vaccine to health officials in Indonesia, who said Health Minister Budi Gunadi Sadikin from monitoring the vaccination results to 25,374 health workers in Jakarta for 28. The day after two doses of the vaccine, the vaccine was able to protect them from deaths 100 percent and 96 percent from serious illness, hospitalization and 94 percent protection against infection.
The report states that The results were significantly higher than those obtained from clinical trials, but it was not possible to determine which strains of the Sinovac vaccine were effective against in Indonesia. In addition, there was no clear report that Are those health workers screened regularly for the virus in cases of asymptomatic?
However, from such vaccination trials in fact Shows that the Sinovac vaccine’s ability to suppress the epidemic Most people are required to be vaccinated. However, for countries that are developing countries Have low health infrastructure And limited access to images Making it impossible to rapidly distribute access to the vaccine
Images from Seda Yalova / Shutterstock.com.
Apart from public health workers in Indonesia From studying in Brazil At Serrana In the state of sao paulo Of which 45,000 people found that nearly 100 percent of those who received the full dose of vaccination. With severe illness and fewer death
However, on the other hand In Chile, another outbreak of covid-19 has been reported after the Sinovac vaccination accounted for more than a third of the 19 million people, one of the fastest in the world. But it was not fast enough to stop the spread of the virus, but Sinovac Chief Executive Yin Weidong said among those who received the injection. Chilean vaccine, 89 percent, can prevent severe COVID-19 illnesses.
At the moment, the key question for all the COVID vaccines available around the world is: Can it prevent or stop the spread of the virus, which Yin Weidong said about the company’s vaccine. “Although still do not know whether the Sinovac vaccine That is a traditional inactivated vaccine Can it stop or reduce the virus infection in the first place? But the fact that it can help prevent serious illness and reduce mortality is more important.
Thanks for information from Bloomberg.